US Patent Issued to Liangjiang Medicine on Sept. 8 for "Prodrugs for sustained releasing therapeutic agents and uses thereof" (Chinese, Canadian, American Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,729,186, issued on Sept. 8, was assigned to Liangjiang Medicine Co. Ltd. (Chongqing, China).

"Prodrugs for sustained releasing therapeutic agents and uses thereof" was invented by Liyan Xu (Chongqing, China), Yong Liu (Chongqing, China), Weijiang Zhang (Redwood City, Calif.), Hao Zhang (Foster City, Calif.), Xiaohuan Tang (Chongqing, China), Xiaoli Shen (Chongqing, China) and Xingchun Fang (Coquitlam, Canada).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to prodrugs for sustained releasing therapeutic agents, and methods for using such prodrugs for the treatment of diseases. The present disclosure provides a prodrug compou...